| Serial Number | 79296890 |
| Word Mark | EXOTHERA |
| Filing Date | Friday, September 18, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 24, 2021 |
| Registration Number | 6458341 |
| Registration Date | Tuesday, August 24, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 8, 2021 |
| Goods and Services | Custom manufacturing of biologics, namely, manufacturing of biologics using biological organisms in the manufacturing process; custom manufacturing of pharmaceuticals, antibiotic medicines and materials for clinical trials and for commercial supply by pharmaceutical compounders; bio manufacturing for others, namely, custom manufacturing of pharmaceuticals and materials for clinical trials for commercial supply, using biological organisms in the manufacturing process; custom manufacturing services in the field of biologics, pharmaceuticals, biopharmaceuticals, health care, cell culture and gene therapy and medical products; custom manufacturing of medications and parts of medications on the base of specific compositions or active constituents for others to support clinical trials and commercial supply; treatment of pharmaceutical and chemical products and their components during the custom manufacture of pharmaceuticals and biopharmaceuticals; providing advice related to the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply; providing information in the field of the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply |
| Goods and Services | Scientific research and development applied in particular in the biological, technological and biotechnological fields, in the medical, biomedical, chemical, pharmaceutical and veterinary fields, in the fields of immunology, epidemiology, vaccinology and therapies and in the field of gene and cellular therapy; scientific and technological research and development for the pharmaceutical and biotechnology industries; quality control services on pharmaceutical products for others; scientific research and technological development and advice services, namely, analytical testing, biosafety testing, reporting and laboratory services for others, custom design and development of chemical reagents and biochemical assays, formulation and process development for the manufacturing of medicinal products; engineering services; scientific and technological consultancy on process development relating to manufacture of biologics; industrial process development for manufacturing of medical preparations; engineering services and scientific and technological consultancy, all on production units for the development of biologics; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; biochemical engineering services; technical engineering services in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; technological development services, technology advice and information services and engineering consultation services in the field of the production of biologics; scientific research services in the medical sector, namely, conducting clinical trials for others; providing scientific research information in the medical sector, in the field of clinical trials; scientific laboratory services related to the culture of stem cells or differentiated cells and biological materials to be used in cellular therapies and in clinical trials and for the manufacturing of commercial products |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 2, 2020 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 2, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EXOTHERA, société anonyme |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Party Name | EXOTHERA, société anonyme |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Party Name | EXOTHERA, société anonyme |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Event Date | Event Description |
| Saturday, June 3, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, February 28, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, February 4, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, February 3, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 24, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 24, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 29, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 29, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, June 29, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, June 8, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 8, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 19, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, May 9, 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, May 6, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, April 29, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 28, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 28, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 22, 2021 | REFUSAL PROCESSED BY IB |
| Friday, February 26, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, February 26, 2021 | REFUSAL PROCESSED BY MPU |
| Saturday, February 6, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, February 5, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 3, 2021 | ASSIGNED TO EXAMINER |
| Friday, November 6, 2020 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 2, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 29, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |